Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer

Casey Liveringhouse, Bradford A. Perez, Tawee Tanvetyanon et al.|International Journal of Radiation Oncology*Biology*Physics|2023

Cited by 18